1. Home
  2. Active Ingredient Index
  3. Buprenorphine

Active Ingredient Buprenorphine

Active Ingredient Details

What is Buprenorphine?

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

What is the usage for Buprenorphine?

This medication is used to help relieve severe ongoing pain (such as due to arthritis, chronic back pain). Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (7.5, 10, 15, or 20 micrograms per hour patches) should be used only if you have been regularly taking moderate amounts of opioid pain medication. These strengths may cause overdose (even death) if used by a person who has not been regularly taking opioids. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional ("as needed") use.

How many products in the NDC database contain Buprenorphine?

The NDC database has 54 products with the active ingredient Buprenorphine. The following table lists all the products that have this active ingredient.

NDC Products with Buprenorphine

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0093-3239Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalTeva Pharmaceuticals Usa, Inc.ACTIVE
0093-3656Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalTeva Pharmaceuticals Usa, Inc.ACTIVE
0093-3657Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalTeva Pharmaceuticals Usa, Inc.ACTIVE
0093-3658Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalTeva Pharmaceuticals Usa, Inc.ACTIVE
0093-3659Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalTeva Pharmaceuticals Usa, Inc.ACTIVE
0406-3205Proprietary Name: Buprenorphine BasePowderSpecgx LlcACTIVE
0792-0631Proprietary Name: BuprenorphinePowderSiegfried Usa, LlcACTIVE
10920-593Proprietary Name: BuprenorphinePowderArevipharma GmbhACTIVE
12496-0100Proprietary Name: Sublocade BuprenorphineSolutionSubcutaneousIndivior Inc.ACTIVE
12496-0300Proprietary Name: Sublocade BuprenorphineSolutionSubcutaneousIndivior Inc.ACTIVE
12578-607Proprietary Name: BuprenorphinePowderJanssen Pharmaceutica NvACTIVE
12707-036Proprietary Name: BuprenorphinePowderMacfarlan Smith LimitedACTIVE
17205-100Proprietary Name: Buprenorphine BasePowderSiegfried AgACTIVE
38779-3255Proprietary Name: BuprenorphinePowderMedisca IncACTIVE
42858-353Proprietary Name: Buprenorphine BuprenorphinePatchTransdermalRhodes Pharmaceuticals L.p.ACTIVE
42858-493Proprietary Name: Buprenorphine BuprenorphinePatchTransdermalRhodes Pharmaceuticals L.p.ACTIVE
42858-586Proprietary Name: Buprenorphine BuprenorphinePatchTransdermalRhodes Pharmaceuticals L.p.ACTIVE
42858-750Proprietary Name: Buprenorphine BuprenorphinePatchTransdermalRhodes Pharmaceuticals L.p.ACTIVE
42858-839Proprietary Name: Buprenorphine BuprenorphinePatchTransdermalRhodes Pharmaceuticals L.p.ACTIVE
47781-406Proprietary Name: Buprenorphine Transdermal System BuprenorphinePatch, Extended ReleaseTransdermalAlvogen Inc.ACTIVE
47781-407Proprietary Name: Buprenorphine Transdermal System BuprenorphinePatch, Extended ReleaseTransdermalAlvogen Inc.ACTIVE
47781-408Proprietary Name: Buprenorphine Transdermal System BuprenorphinePatch, Extended ReleaseTransdermalAlvogen Inc.ACTIVE
47781-419Proprietary Name: Buprenorphine Transdermal System BuprenorphinePatch, Extended ReleaseTransdermalAlvogen Inc.ACTIVE
47848-030Proprietary Name: BuprenorphinePowderTeva Czech Industries S.r.oACTIVE
49812-0239Proprietary Name: BuprenorphinePowderVeranova, L.p.ACTIVE
50742-372Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalIngenus Pharmaceuticals, LlcACTIVE
50742-373Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalIngenus Pharmaceuticals, LlcACTIVE
50742-374Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalIngenus Pharmaceuticals, LlcACTIVE
50742-375Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalIngenus Pharmaceuticals, LlcACTIVE
50742-376Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalIngenus Pharmaceuticals, LlcACTIVE
58064-408Proprietary Name: Buprenorphine Transdermal System BuprenorphinePatch, Extended ReleaseTransdermalLts Therapy Systems, LlcACTIVE
58284-208Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-216Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-224Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-228Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-232Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-264Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
58284-296Proprietary Name: Brixadi BuprenorphineInjectionSubcutaneousBraeburn Inc.ACTIVE
59011-750Proprietary Name: Butrans BuprenorphinePatch, Extended ReleaseTransdermalPurdue Pharma LpACTIVE
59011-751Proprietary Name: Butrans BuprenorphinePatch, Extended ReleaseTransdermalPurdue Pharma LpACTIVE
59011-752Proprietary Name: Butrans BuprenorphinePatch, Extended ReleaseTransdermalPurdue Pharma LpACTIVE
59011-757Proprietary Name: Butrans BuprenorphinePatch, Extended ReleaseTransdermalPurdue Pharma LpACTIVE
59011-758Proprietary Name: Butrans BuprenorphinePatch, Extended ReleaseTransdermalPurdue Pharma LpACTIVE
62175-452Proprietary Name: Buprenorphine And Naloxone Buprenorphine And NaloxoneTabletSublingualLannett Company, Inc.ACTIVE
62175-458Proprietary Name: Buprenorphine And Naloxone Buprenorphine And NaloxoneTabletSublingualLannett Company, Inc.ACTIVE
65267-203Proprietary Name: BuprenorphinePowderJanssen Pharmaceutical Sciences Unlimited CompanyACTIVE
65724-0050Proprietary Name: BuprenorphinePowderSiegfried Pharmachemikalien Minden GmbhACTIVE
69238-1202Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalAmneal Pharmaceuticals Ny LlcACTIVE
69238-1203Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalAmneal Pharmaceuticals Ny LlcACTIVE
69238-1204Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalAmneal Pharmaceuticals Ny LlcACTIVE
69238-1205Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalAmneal Pharmaceuticals Ny LlcACTIVE
69238-1505Proprietary Name: Buprenorphine BuprenorphinePatch, Extended ReleaseTransdermalAmneal Pharmaceuticals Ny LlcACTIVE
71795-2200Proprietary Name: BuprenorphinePowderIndivior Uk LimitedACTIVE
73548-1039Proprietary Name: BuprenorphinePowderPurisys LlcACTIVE
<